Part of the renowned Braunwald family of references, Diabeto-Cardiology, 2nd Edition, provides today’s clinicians with clear, authoritative guidance on the complex challenges of providing care to patients with cardiovascular and diabetes co-morbidities. Drs. Darren K. McGuire and Nikolaus Marx, along with a leading team of experts in cardiology and diabetes, address boththe foundational aspects and clinical implications for this growing number of patients, including recent breakthrough therapies and new medications that have contributed to newer and more effective treatments and improved patient outcomes. From cover to cover, this second edition offers reliable and current point-of-care coverage of the interwoven care needs of patients with these complex co-morbidities, making it an ideal resource for practitioners at all levels of experience.
PART I DIABETES MELLITUS 1 Definition and Epidemiology of Type 2 Diabetes Mellitus 2 Insulin Resistance: Pathophysiology, Molecular Mechanisms, and Genetic Insights 3 Lifestyle Interventions for the Prevention of Type 2 Diabetes Mellitus 4 Pharmacological and Surgical Interventions That Prevent or Remit Type 2 Diabetes 5 Type 1 Diabetes: Pathophysiology and Treatment Considerations for Cardiovascular Risk and Disease PART II CARDIOVASCULAR COMPLICATIONS OF TYPE 2 DIABETES 6 Epidemiology of Diabetes Mellitus and Atherosclerotic Cardiovascular Disease 7 Pathology and Vascular Biology of Atherosclerosis in Patients With Type 2 Diabetes 8 Risk Stratification Among Patients With Type 2 Diabetes With or at Risk for Atherosclerotic Cardiovascular Disease 9 Epidemiology and Pathophysiology of Heart Failure With Preserved and With Reduced Ejection Fraction in Patients With Type 2 Diabetes PART III EFFECTS OF ANTIHYPERGLYCEMIC THERAPIES FOR TYPE 2 DIABETES ON CARDIOVASCULAR AND KIDNEY OUTCOMES 10 Effect of Glucose Management on Coronary Heart Disease Risk in Patients With Type 2 Diabetes 11 Regulatory Approach to Medications for Type 2 Diabetes: Past, Present, and Future 12 Cardiovascular and Kidney Effects of Sodium Glucose Cotransporter Inhibitors 13 Cardiovascular and Kidney Effects of Glucagon-Like Peptide 1 Receptor Agonists 14 Antihyperglycemic Medications With Proven Cardiovascular Safety 15 Prevention of Heart Failure in People With Diabetes 16 Treatment of Patients With Reduced and With Preserved Ejection Fraction Heart Failure in Patients With Type 2 Diabetes PART IV MANAGEMENT OF CORONARY HEART DISEASE RISK CHRONIC AND ACUTE CORONARY SYNDROMES IN PATIENTS WITH TYPE 2 DIABETES 17 Effect of Lifestyle Interventions on Coronary Heart Disease Risk in Patients With Type 2 Diabetes 18 Effect of Blood Pressure Management on Coronary Heart Disease Risk in Patients With Type 2 Diabetes 19 Effect of Lipid Management on Coronary Heart Disease Risk in Persons With Type 2 Diabetes 20 Effect of Antithrombotic Therapy on Coronary Heart Disease Risk in People With Diabetes Mellitus 21 Role of Percutaneous Coronary Intervention in Patients With Diabetes PART V OTHER CARDIOVASCULAR CONSIDERATIONS FOR PATIENTS WITH TYPE 2 DIABETES 22 Peripheral Artery Disease in Persons With Type 2 Diabetes 23 Cerebrovascular Disease in Persons With Diabetes 24 Atrial Fibrillation in Persons With Type 2 Diabetes 25 Chronic Kidney Disease: Implications for Cardiovascular Risk and Management in Patients With Type 2 Diabetes 26 Disparities in Type 2 Diabetes Risk, Cardiovascular Consequences, and Care: Females, Racial/Ethnic Minorities, and the Elderly 27 The Quality Chasm and the Need for Implementation Science to Reduce Cardiovascular Disease Risk in Type 2 Diabetes
Komentarze (0)
Chwilowo nie możesz polubić tej opinii
Zgłoś komentarz
Czy jesteś pewien, że chcesz zgłosić ten komentarz?
Zgłoszenie wysłane
Twój komentarz został wysłany i będzie widoczny po zatwierdzeniu przez moderatora.